Search Results
Optimizing LDL-C Lowering With PCSK9 Inhibition
Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?
A Real World Approach to LDL cholesterol using PCSK9 inhibitors, October 5 2018
Dr Aruna Pradhan - Have we reached the limits of lipid lowering? What next? - Full version
I Lowered My Apolipoprotein B (ApoB) by 34% | No Insulin Resistance or Drugs
PCSK9 Inhibition: Lowering Lipids and Reducing Cardiovascular Events
Pushing the Envelope with PCSK9-Twenty Years of Progress
Are PCSK9 Inhibitors for LDL Cholesterol Safe and Effective?
Safety and Efficacy of Very Low LDL-C (FOURIER-OLE Trial)
Scientific Insights Into LDL-C, PCSK9, and CV RISKS
Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C in Hyperlipidemia and ASCVD
The Cholesterol Wars: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Part 1)
